Grimes, Julia A. Ph.D.

Lawyer Overview

Dr. Julia Grimes is a senior associate in the firm's Intellectual Property Department. She joined the firm in 2006. 

Practice

Dr. Grimes' practice focuses on patent prosecution, patent portfolio management, patentability assessment, freedom-to-operate analysis, due diligence, and other areas of client counseling in the biotechnology field.

Past Experience

Prior to joining WilmerHale, Dr. Grimes worked as a scientific advisor at another New York law firm.

Dr. Grimes spent two years working in technology transfer for the UK Medical Research Council, where she was responsible for procurement and licensing of the oncology, virology and neuroscience patent portfolios.

From 1996 to 2000, Dr. Grimes was a Howard Hughes Medical Institute post-doctoral fellow in the Department of Neurobiology at the State University of New York, Stony Brook. Her postdoctoral research focused on the regulation of gene expression in the nervous system.

Dr. Grimes received her PhD from Imperial College, University of London, where her thesis research involved the cell biology of cancer metastasis.

Professional Activities

Dr. Grimes is an Associate of the Royal College of Science.

Areas of Practice

• Intellectual Property

West Practice Categories

Copyrights, Intellectual Property Law, International Intellectual Property, Patents, Technology Licensing, Trade Dress, Trade Secrets, Trademarks

Bar Admissions

• New York

Education

• Fordham University School of Law, 2009
  JD
• Imperial College, University of London, 1996
  PhD
  Major: Biology
• Imperial College, University of London, 1992
  BSc
  Honors: First Class Honors
  Major: Biology

Published Works

• Comparative studies of intracellular calcium in strongly and weakly metastatic rat prostate cancer cell lines, 2006
• Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell line: electrophysiological, pharmacological and molecular characterization, 2003
• Effects of voltage-gated ion channel modulators on rat prostatic cancer cell proliferation: Comparison of highly and weakly metastatic cell lines, 2000
• The co-repressor mSin3A is a functional component of the REST/CoREST repressor complex, 2000
• CoREST: A functional co-repressor required for regulation of neural-specific gene expression, 1999
• Electrophysiological characterization of a voltage-gated Na+ current expressed in the highly metastatic Mat-LyLu rat prostate cancer cell line, 1998
• Expression and functional analysis of voltage-activated Na+ channels in human prostate cancer cell lines and their contribution to invasion in vitro, 1997
• Voltage-gated K+ current in the highly metastatic MAT-LyLu rat prostate cancer cell line: Electrophysiological and pharmacological characteristics, 1996
• Electrophysiological characterization of a TTX-sensitive Na+ current in the highly metastatic MAT-LyLu rat prostate cancer cell line, 1995
• Differential expression of voltage-activated Na+ currents in two prostatic tumour cell lines: Contribution to invasiveness in vitro, 1995

Address

399 Park Avenue
New York, NY 10022

Phones

+1 212 295 6393 (Business Phone)

Faxes

+1 212 230 8888 (Business Fax)

Emails

Contact Us (Business Email)

Websites

http://www.wilmerhale.com